Chemokines
Product List
LAG-1 Human
LAG-1 Human Recombinant (CCL4L1)
The CCL4L1 is purified by proprietary chromatographic techniques.
LAG-1 Human, His
LAG-1 (CCL4L1) Human Recombinant, His Tag
LAG-1 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
MIP 1a Human
Macrophage Inflammatory Protein-1 Alpha Human Recombinant (CCL3)
The MIP-1a is purified by proprietary chromatographic techniques.
MIP 1a Human, His
Macrophage Inflammatory Protein-1 Alpha Human Recombinant (CCL3), His Tag
MIP-1a Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 90 amino acids (24-92 a.a.) and having a molecular mass of 10.0kDa. MIP-1a is fused to a 21 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
MIP 1a Mouse
Macrophage Inflammatory Protein-1 Alpha Mouse Recombinant (CCL3)
The MIP-1a is purified by proprietary chromatographic techniques.
MIP 1a Mouse, His
Macrophage Inflammatory Protein-1 Alpha Mouse Recombinant (CCL3), His Tag
MIP-1a is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
MIP 1a Rat
Macrophage Inflammatory Protein-1 Alpha Rat Recombinant (CCL3)
The MIP-1a is purified by proprietary chromatographic techniques.
MIP 1b Human
Macrophage Inflammatory Protein-1 Beta Human Recombinant (CCL4)
The CCL4 is purified by proprietary chromatographic techniques.
MIP 1b Mouse
Macrophage Inflammatory Protein-1 beta Mouse Recombinant (CCL4)
The MIP-1b is purified by proprietary chromatographic techniques.
MIP 1b Rat
Macrophage Inflammatory Protein-1 beta Rat Recombinant (CCL4)
The MIP-1b is purified by proprietary chromatographic techniques.
Introduction
Macrophage Inflammatory Proteins (MIPs) are a group of chemokines, which are small cytokines involved in the immune response. The MIP family includes several members, notably CCL3, CCL4, CCL9, and CCL15. These chemokines are classified under the CC chemokine family, characterized by two adjacent cysteine residues near their amino terminus .
Key Biological Properties: MIPs are chemotactic cytokines that play crucial roles in immune cell recruitment and activation. They are produced by various cell types, including macrophages, dendritic cells, and lymphocytes .
Expression Patterns and Tissue Distribution:
- CCL3 (MIP-1α) and CCL4 (MIP-1β) are primarily expressed by macrophages and monocytes upon stimulation with bacterial endotoxins or pro-inflammatory cytokines .
- CCL9 is predominantly expressed in the intestines and plays a role in gut immunity .
- CCL15 is expressed in the liver, lungs, and intestines and is involved in recruiting immune cells to sites of inflammation .
Primary Biological Functions:
- CCL3 and CCL4: These chemokines are involved in recruiting and activating various immune cells, including macrophages, lymphocytes, and eosinophils. They play a significant role in inflammatory responses and pathogen recognition .
- CCL9: It is crucial for the recruitment of dendritic cells to the gut, aiding in the immune surveillance of the intestinal mucosa .
- CCL15: This chemokine recruits monocytes and neutrophils to sites of inflammation, contributing to the body’s defense mechanisms .
Role in Immune Responses and Pathogen Recognition: MIPs are essential for initiating and sustaining immune responses. They help in the recognition and clearance of pathogens by recruiting immune cells to the site of infection .
Mechanisms with Other Molecules and Cells: MIPs interact with specific chemokine receptors on the surface of target cells. For instance, CCL3 and CCL4 bind to CCR1 and CCR5 receptors, triggering downstream signaling pathways that lead to cell migration and activation .
Binding Partners and Downstream Signaling Cascades: Upon binding to their receptors, MIPs activate various intracellular signaling cascades, including the MAPK and NF-κB pathways, which result in the production of additional cytokines and chemokines, amplifying the immune response .
Regulatory Mechanisms Controlling Expression and Activity:
- Transcriptional Regulation: The expression of MIPs is regulated at the transcriptional level by various transcription factors, including NF-κB and AP-1, which are activated in response to inflammatory stimuli .
- Post-Translational Modifications: MIPs undergo post-translational modifications, such as glycosylation, which can affect their stability and activity .
Biomedical Research: MIPs are studied extensively in the context of inflammatory diseases, cancer, and infectious diseases. They serve as biomarkers for disease progression and therapeutic targets .
Diagnostic Tools: Elevated levels of MIPs in biological fluids can indicate the presence of inflammatory conditions or infections, making them valuable diagnostic markers .
Therapeutic Strategies: Targeting MIPs or their receptors with specific inhibitors can modulate immune responses, offering potential therapeutic strategies for treating inflammatory and autoimmune diseases .
